A comparative study of eradication rates, adverse events, and compliance between triple therapy and bismuth-containing quadruple therapy in children with Helicobacter pylori infection

Purpose: ) infection in children. Methods: C-urea breath test 4 weeks post-treatment. Secondary outcomes included changes in abdominal pain, bloating, and nausea scores (measured by a 4-point Likert scale before and after treatment) and the incidence of adverse events. Results: = 0.018). Conclusion: and alleviating associated symptoms in children, with a similar safety and compliance profile.